Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 4/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.60 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.60 |
| ▸ | PTPN7 | P35236 | 3/20 | 0.54 |
| ▸ | HMGCR | P04035 | 3/20 | 0.54 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 3/20 | 0.48 |
| ▸ | PPARD | Q03181 | 3/20 | 0.48 |
| ▸ | PPARA | Q07869 | 3/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL979048 | 1.00 | HSD17B10 (1.00) | HSD17B10CYP1A2CYP2D6MAPTCYP2C9 | |
| SCHEMBL1050169 | 1.00 | HSD17B10 (1.00) | HSD17B10CYP1A2CYP2D6MAPTCYP2C9 | |
| SCHEMBL2802414 | 1.00 | HSD17B10 (1.00) | HSD17B10CYP1A2CYP2D6MAPTCYP2C9 | |
| SCHEMBL20293445 | 1.00 | HSD17B10 (1.00) | HSD17B10CYP1A2CYP2D6MAPTCYP2C9 | |
| SCHEMBL2803510 | 1.00 | HSD17B10 (1.00) | HSD17B10CYP1A2CYP2D6MAPTCYP2C9 | |
| SCHEMBL2985078 | 1.00 | HSD17B10 (1.00) | HSD17B10CYP1A2CYP2D6MAPTCYP2C9 | |
| SCHEMBL740489 | 1.00 | HSD17B10 (1.00) | HSD17B10CYP1A2CYP2D6MAPTCYP2C9 | |
| SCHEMBL12680242 | 1.00 | HSD17B10 (1.00) | HSD17B10CYP1A2CYP2D6MAPTCYP2C9 | |
| SCHEMBL257132 | 1.00 | HSD17B10 (1.00) | HSD17B10CYP1A2CYP2D6MAPTCYP2C9 | |
| SCHEMBL29377936 | 1.00 | HSD17B10 (1.00) | HSD17B10CYP1A2CYP2D6MAPTCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 518 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12618844-B2 | Cancer | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2026-05-05 | — | — | US | claimed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| EP-4617320-A1 | HALOGEN-FREE FLAME-RETARDANT GLASS FIBER REINFORCED NYLON MATERIAL, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Shanghai Zhonglei New Material Science Co., Ltd. (CN) | 2025-09-17 | — | — | EP | claimed |
| CN-120136965-A | Isolated polypeptide of targeted MPP8 protein and application thereof | 苏州系统医学研究所 | 2025-06-13 | — | — | CN | claimed |
| WO-2025077276-A1 | REACTION SITE-CONTROLLABLE, LIGHT-INDUCED QUANTUM DOT PHOTOLITHOGRAPHY PATTERNING METHOD, AND APPLICATION THEREOF | 中国科学院宁波材料技术与工程研究所 | 2025-04-17 | — | — | WO | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| WO-2024098807-A1 | HALOGEN-FREE FLAME-RETARDANT GLASS FIBER REINFORCED NYLON MATERIAL, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 上海中镭新材料科技有限公司 | 2024-05-16 | — | — | WO | claimed |
| CN-117311091-A | Photo-induced quantum dot photoetching patterning method with controllable reaction sites and application thereof | 宁波杭州湾新材料研究院 | 2023-12-29 | — | — | CN | claimed |
| US-20230068371-A1 | CANCER | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2023-03-02 | — | — | US | claimed |
| CN-111592035-B | Preparation method of CsPbBr3 spindle-type perovskite micron particles with adjustable size | 南京工业大学 | 2022-09-20 | — | — | CN | claimed |
| CN-1211261-A | Water-dispersible polymer and coating composition containing the same | DEXTER CORP (US) | 1999-03-17 | — | — | CN | claimed |
| US-5869552-A | HAVING STRUCTURE WITH EPOXY PORTION LINKED TO ACRYLIC PORTION BY COMPOUND HAVING EITHER CONJUGATED DOUBLE BONDS OR TRIPLE BOND AND MOIETY CAPABLE OF REACTING WITH EPOXY GROUP | THE DEXTER CORPORATION (US) | 1999-02-09 | — | — | US | claimed |
| EP-0882080-A1 | WATER-DISPERSIBLE POLYMER AND COATING COMPOSITION CONTAINING THE SAME | THE DEXTER CORPORATION (US) | 1998-12-09 | — | — | EP | claimed |
| US-5837146-A | HOMOGENOUS THERMAL REACTION PRODUCT OF AN ALKYL(METH)ACRYLATE (CO)POLYMER MODIFIED WITH UNSATURATED OIL COMPONENT SUCH AS GLYCERIDE, FATTY ACID, ALKENE, AND/OR ALKYNE; FOR CLEANING ENVIRONMENTAL OIL SPILLS ON WATER | MANSFIELD & ALPER, INC. (US) | 1998-11-17 | — | — | US | claimed |
| US-5830952-A | ACRYLIC POLYMERS LINKED TO EPOXY COMPOUNDS OR POLYMERS | THE DEXTER CORPORATION (US) | 1998-11-03 | — | — | US | claimed |
| EP-0871593-A1 | OIL COAGULANT PRODUCTS AND METHODS OF USE THEREFOR | Mansfield & Alper, Inc. (US) | 1998-10-21 | — | — | EP | claimed |
| WO-1997031044-A1 | WATER-DISPERSIBLE POLYMER AND COATING COMPOSITION CONTAINING THE SAME | THE DEXTER CORPORATION (US) | 1997-08-28 | — | — | WO | claimed |
| WO-1997022558-A1 | OIL COAGULANT PRODUCTS AND METHODS OF USE THEREFOR | MANSFIELD & ALPER, INC. (US) | 1997-06-26 | — | — | WO | claimed |
| EP-0450742-B1 | DTPA-Monoamids, pharmaceutical compositions containing them, their use and process for their preparation | SCHERING AG (DE) | 1994-07-06 | — | — | EP | claimed |
| US-4405776-A | 3-METHYLCYCLOPENTENE, SULFUR DIOXIDE | RCA CORPORATION (US) | 1983-09-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12618844-B2 | Cancer | FABP2, CA12, CA13 | HSD17B10 406/4885CYP1A2 3681/4885CYP2D6 2607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.